blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2908832

EP2908832 - METHOD OF PREVENTION AND TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  08.09.2017
Database last updated on 12.11.2024
FormerRequest for examination was made
Status updated on  01.03.2017
Most recent event   Tooltip08.09.2017Application deemed to be withdrawnpublished on 11.10.2017  [2017/41]
Applicant(s)For all designated states
Polonez Therapeutics LLC
1461 Wrightstown Road
Newtown, Pennsylvania 18940 / US
[2015/35]
Inventor(s)01 / BOCHENEK, Wieslaw, J.
1461 Wrightstown Road
Newtown, Pennsylvania 18940 / US
02 / CORRADO, Michael, L.
1309 Seven Corner Road
Perkasie, Pennsylvania 18944 / US
 [2015/35]
Representative(s)Belz, Anna
ul. Pólnocna 6/24
20-064 Lublin / PL
[N/P]
Former [2015/35]Belz, Anna
Polnocna 6/24
20-064 Lublin / PL
Application number, filing date13849112.110.10.2013
[2015/35]
WO2013US64278
Priority number, dateUS20121365712422.10.2012         Original published format: US201213657124
[2015/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2014066053
Date:01.05.2014
Language:EN
[2014/18]
Type: A2 Application without search report 
No.:EP2908832
Date:26.08.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 01.05.2014 takes the place of the publication of the European patent application.
[2015/35]
Search report(s)International search report - published on:US16.07.2015
(Supplementary) European search report - dispatched on:EP27.06.2016
ClassificationIPC:A61K47/00, A61K35/74, A61K36/064, A61K36/06, A61K9/48, A61K45/06, A61K47/32, A61K9/52, A61P31/04
[2016/30]
CPC:
A61K9/4891 (EP,US); A61J1/035 (US); A61K35/741 (EP,US);
A61K35/742 (US); A61K35/744 (US); A61K35/745 (US);
A61K35/747 (US); A61K36/06 (EP,US); A61K36/064 (EP,US);
A61K45/06 (EP,US); A61P1/00 (EP); A61P1/14 (EP);
A61P31/04 (EP); B65D75/367 (US); B65D75/58 (US) (-)
C-Set:
A61K35/741, A61K2300/00 (EP,US);
A61K36/064, A61K2300/00 (US,EP);
A61K36/06, A61K2300/00 (US,EP)
Former IPC [2015/38]A61K47/00
Former IPC [2015/35]A61K35/74, A61K9/50, A61K9/48, A61K9/52, A61K9/20, A61K9/00, A61K36/064, A61K36/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/35]
TitleGerman:VERFAHREN ZUR PRÄVENTION UND BEHANDLUNG VON CLOSTRIDIUM DIFFICILE-INFEKTIONEN[2015/35]
English:METHOD OF PREVENTION AND TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION[2015/35]
French:PROCÉDÉ DE PRÉVENTION ET DE TRAITEMENT D'UNE INFECTION PAR LE CLOSTRIDIUM DIFFICILE[2015/35]
Entry into regional phase21.05.2015National basic fee paid 
21.05.2015Search fee paid 
21.05.2015Designation fee(s) paid 
21.05.2015Examination fee paid 
Examination procedure21.05.2015Examination requested  [2015/35]
29.02.2016Amendment by applicant (claims and/or description)
25.01.2017Application deemed to be withdrawn, date of legal effect  [2017/41]
02.03.2017Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/41]
Fees paidRenewal fee
26.10.2015Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
31.10.201604   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]US2007178070  (KAUL POONAM [US], et al) [X] 1-3,5-7 * paragraph [0010] - paragraph [0011]; example 10 * * paragraph [0044] - paragraph [0048] * [Y] 4,8-15;
 [XY]WO2011004375  (RUBIN ISRAEL [IL], et al) [X] 1-3,5,7 * page 6, paragraph 2 - page 11, paragraph 1; claims 1-15 * [Y] 4,8-15;
 [XI]  - MARIYA I. BRACHKOVA ET AL, "Evaluation of the viability of Lactobacillus spp. after the production of different solid dosage forms", JOURNAL OF PHARMACEUTICAL SCIENCES, WASHINGTON, US, (20090901), vol. 98, no. 9, doi:10.1002/jps.21609, ISSN 0022-3549, pages 3329 - 3339, XP055280459 [X] 1-3,5-7 * page 3331, column 2, paragraph 2 - page 3332, column 1, paragraph 3 * * page 3336, column 1, paragraph 3 - page 3338, column 2, paragraph 5 * [I] 1-11

DOI:   http://dx.doi.org/10.1002/jps.21609
 [A]  - AN THYSSEN ET AL, "Randomized, Open-Label, Single-Dose, Crossover, Relative Bioavailability Study in Healthy Adults, Comparing the Pharmacokinetics of Rabeprazole Granules Administered Using Soft Food or Infant Formula as Dosing Vehicle Versus Suspension", CLINICAL THERAPEUTICS, EXCERPTA MEDICA, PRINCETON, NJ, US, vol. 34, no. 7, doi:10.1016/J.CLINTHERA.2012.06.008, ISSN 0149-2918, (20120606), pages 1636 - 1645, (20120620), XP028405393 [A] 12-15 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.clinthera.2012.06.008
International search[X]US2011240512  (DORFNER SCOTT [US]);
 [Y]US2004028689  (BORODY THOMAS JULIUS [AU]);
 [Y]US2011020305  (FARMER SEAN [US]);
 [Y]WO2011005756  (PURETECH VENTURES LLC [US], et al);
 [Y]US2007248582  (LUQUET FRANCOIS-MARIE [FR])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.